GSK transfers Ultiva to Aspen in Australia
Read more - GSK transfers Ultiva to Aspen in Australia Read more
Press releases
These press releases are intended for business journalists and analysts/investors
Bexsero (meningococcal B) vaccine availability
Read more - Bexsero (meningococcal B) vaccine availability Read more
Collaboration and mentorship prove winning formula for manufacturing
Read more - Collaboration and mentorship prove winning formula for manufacturing Read more
GSK welcomes Medicines Australia strategic agreement
Read more - GSK welcomes Medicines Australia strategic agreement Read more
GSK Australia Reports 2016 results to ASIC
Read more - GSK Australia Reports 2016 results to ASIC Read more
Statement on arachnoiditis and myelograms
GSK has the utmost sympathy for the people who have been, and are, afflicted by arachnoiditis. It can be a very debilitating and painful condition.
Arachnoiditis has a range of possible causes such as spinal injury, surgery and infection. However, it is difficult to determine the causality of arachnoiditis.
Read more - Statement on arachnoiditis and myelograms Read more
GSK responds to Cyclone Debbie
Availability of Menveo (meningococcal ACWY vaccine)
Read more - Availability of Menveo (meningococcal ACWY vaccine) Read more
Bexsero® (Meningococcal B) vaccine availability
Read more - Bexsero® (Meningococcal B) vaccine availability Read more
GSK discloses $28,375 in payments to HCPs
Read more - GSK discloses $28,375 in payments to HCPs Read more